Unknown

Dataset Information

0

Evaluation of Acute 13-Week Subchronic Toxicity and Genotoxicity of the Powdered Root of Tongkat Ali (Eurycoma longifolia Jack).


ABSTRACT: Tongkat Ali (Eurycoma longifolia) is an indigenous traditional herb in Southern Asia. Its powdered root has been processed to produce health supplements, but no detailed toxicology report is available. In this study, neither mutagenicity nor clastogenicity was noted, and acute oral LD50 was more than 6?g/kg b.w. After 4-week subacute and 13-week subchronic exposure paradigms (0, 0.6, 1.2, and 2?g/kg b.w./day), adverse effects attributable to test compound were not observed with respect to body weight, hematology, serum biochemistry, urinalysis, macropathology, or histopathology. However, the treatment significantly reduced prothrombin time, partial thromboplastin time, blood urea nitrogen, creatinine, aspartate aminotransferase, creatine phosphate kinase, lactate dehydrogenase, and cholesterol levels, especially in males (P < 0.05). These changes were judged as pharmacological effects, and they are beneficial to health. The calculated acceptable daily intake (ADI) was up to 1.2 g/adult/day. This information will be useful for product development and safety management.

SUBMITTER: Li CH 

PROVIDER: S-EPMC3767077 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Evaluation of Acute 13-Week Subchronic Toxicity and Genotoxicity of the Powdered Root of Tongkat Ali (Eurycoma longifolia Jack).

Li Ching-Hao CH   Liao Jiunn-Wang JW   Liao Po-Lin PL   Huang Wei-Kuang WK   Tse Ling-Shan LS   Lin Cheng-Hui CH   Kang Jaw-Jou JJ   Cheng Yu-Wen YW  

Evidence-based complementary and alternative medicine : eCAM 20130825


Tongkat Ali (Eurycoma longifolia) is an indigenous traditional herb in Southern Asia. Its powdered root has been processed to produce health supplements, but no detailed toxicology report is available. In this study, neither mutagenicity nor clastogenicity was noted, and acute oral LD50 was more than 6 g/kg b.w. After 4-week subacute and 13-week subchronic exposure paradigms (0, 0.6, 1.2, and 2 g/kg b.w./day), adverse effects attributable to test compound were not observed with respect to body w  ...[more]

Similar Datasets

| S-EPMC3739276 | biostudies-other
| S-EPMC6130542 | biostudies-literature
| S-EPMC9324291 | biostudies-literature
| S-EPMC6270735 | biostudies-literature
| S-EPMC3971761 | biostudies-literature
| PRJNA369289 | ENA
| PRJNA297259 | ENA
| S-EPMC5551365 | biostudies-other
| S-EPMC6749187 | biostudies-other
| S-EPMC8512324 | biostudies-literature